Small Molecule Therapeutics for Schizophrenia

The topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drug ability of targets, drug design approaches, chemogenomics, synthetic chemistry i...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Celanire, Sylvain (Editor), Poli, Sonia (Editor)
Format: Electronic eBook
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2015.
Series:Topics in Medicinal Chemistry, 13
Subjects:
Online Access:Full Text via HEAL-Link
Table of Contents:
  • Antipsychotics and the Dopamine–Serotonin Connection
  • GLYT1 Inhibitors: From Hits to Clinical Candidates
  • Metabotropic Glutamate Receptor 2 Activators
  • Activation of the mGlu5 Receptor for the Treatment of Schizophrenia and Cognitive-Deficit-Associated Disorders
  • Muscarinic Acetylcholine Receptor Activators
  • Nicotinic Acetylcholine Receptor Modulators
  • The Use of PDE10A and PDE9 Inhibitors for Treating Schizophrenia.